SCHEMBL19449240

SCHEMBL19449240

C/C(=N\Nc1nc2cc(F)c(C)cc2n1C)c1ncccn1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MT-CO1 P00395 2/20 0.84
▸ MT-CO2 P00403 2/20 0.84
▸ EDNRA P25101 1/20 0.55
▸ OPRM1 P35372 1/20 0.55
▸ HTR2B P41595 1/20 0.55
▸ KCNH2 Q12809 1/20 0.55
▸ HSP90AA1 P07900 2/20 0.43
▸ PAX8 Q06710 2/20 0.37
▸ RAB9A P51151 6/20 0.35
▸ MAPT P10636 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HTT P42858 2/20 0.35
▸ TRPV1 Q8NER1 2/20 0.34
▸ ALOX15 P16050 1/20 0.33
▸ NPC1 O15118 5/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ GAA P10253 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19449242 0.91 MT-CO1 (1.00) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449212 0.87 MT-CO1 (0.64) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL21844902 0.82 MT-CO1 (0.79) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449277 0.82 MT-CO1 (0.75) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449213 0.81 MT-CO1 (0.59) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449224 0.81 MT-CO1 (0.69) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449235 0.80 MT-CO1 (0.85) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449244 0.78 MT-CO1 (0.76) MT-CO1MT-CO2EDNRAOPRM1HTR2B
SCHEMBL19449221 0.78 MT-CO1 (0.67) MT-CO1MT-CO2HSP90AA1PAX8RAB9A
SCHEMBL19449245 0.72 MT-CO1 (0.69) MT-CO1MT-CO2EDNRAOPRM1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170290830-A1 SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF BAYLOR COLLEGE OF MEDICINE (US) 2017-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170290830-A1 SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF NCOA2, NCOA3, NCOA1 MT-CO1 2559/4885MT-CO2 3459/4885EDNRA 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback